A 55 year-old man with unstable angina is treated with an intravenously administered glycoprotein IIb - IIIa inhibitor. The mechanism of action of this agent is the ability to.
Dilate coronary arteries Inhibit platelet aggregation Inhibit platelet adhesion Inhibit atherogenesis